Categories: Public Companies

Lexington Biosciences Converts Amounts Owed to Unsecured Demand Loans

VANCOUVER, British Columbia, Oct. 04, 2019 (GLOBE NEWSWIRE) — Lexington Biosciences, Inc. (CSE: LNB) (the “Company” or “Lexington”) announces that it has reached agreement with third parties as well as certain directors and officers (collectively the “lenders”) of the Company to convert previous advances and unpaid amounts for services received of $654,186, in aggregate, into unsecured demand loans bearing interest at 16% per annum. As a result of the interest being applied retroactively to the date the advances or services were made the Company owed these parties $744,203 as at September 30, 2019, which is the aggregate amount of the unsecured demand loans issued.

In consideration for the conversion of the advances into unsecured demand loans, the Company will issue a total of 14,880,465 bonus warrants (“Warrants”) to the lenders at a deemed price per share of $0.05. The Warrants will be exercisable for a period of 24 months into common shares of the Company at a price of $0.05 each.

On Behalf of the Board,

“Eric Willis”

Eric Willis
CEO & Director

CAUTIONARY DISCLAIMER STATEMENT: The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Cautionary Note Regarding Forward-Looking Statements
This news release contains forward-looking statements relating to the potential sale of the HeartSentry technology and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include those relating to the ability to complete the sale and other risks detailed from time to time in the filings made by the Company with securities regulations.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward- looking statements as expressly required by applicable law.

CONTACT:
Lexington Biosciences, Inc.
+1 (800) 320-2640
info@lexingtonbiosciences.com
www.lexingtonbiosciences.com

IR Press

Share
Published by
IR Press

Recent Posts

READOUT: U.S. Treasury Meeting with Argentina’s Chief of Cabinet Nicolás Posse and Foreign Minister Diana Mondino

WASHINGTON – Today, Under Secretary of the Treasury for International Affairs Jay Shambaugh met with…

2 days ago

Acting Comptroller Testifies on Agency Activities

WASHINGTON—Acting Comptroller Michael J. Hsu today testified on the Office of the Comptroller of the…

3 days ago

Remarks by Deputy Secretary of the Treasury Wally Adeyemo at the Vice President’s Economic Opportunity Tour Event in Milwaukee, Wisconsin

As Prepared for DeliveryThank you for the kind introduction. It’s great to be here in…

3 days ago

U.S. Department of the Treasury, IRS Release Additional Guidance to Boost American Clean Energy Manufacturing

Guidance Provides Additional Clarification Around Eligibility Determination for Domestic Content Bonus in the Inflation Reduction…

3 days ago

Treasury Announces 2024 National Illicit Finance Strategy

Strategy Highlights Recent Reforms to Close Loopholes Exploited by Illicit Actors; Recommendations Include Increasing Transparency,…

3 days ago

Treasury Designates Sanctions Evaders Facilitating Illicit Arms Transfers between the DPRK and Russia

WASHINGTON — Today, the U.S. Department of the Treasury’s Office of Foreign Assets Control (OFAC)…

3 days ago